Bert K. Cruyssen-Vander
Aalst, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Refining serological scores in rheumatoid arthritis classification: an international study.
Journal: RMD open
Published: March 30, 2026
Multicenter study to improve clinical interpretation of anticardiolipin and anti-β2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 12, 2025
New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigens.
Journal: Annals of the rheumatic diseases
Published: May 28, 2024
Discriminating signal from noise: the biological variation of circulating calprotectin in serum and plasma.
Journal: Clinical chemistry and laboratory medicine
Published: October 10, 2023
IgA rheumatoid factor in rheumatoid arthritis.
Journal: Clinical chemistry and laboratory medicine
Published: March 15, 2022
Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results.
Journal: RMD open
Published: November 13, 2021
Standardisation of ACPA tests: evaluation of a new candidate reference preparation.
Journal: Annals of the rheumatic diseases
Published: November 13, 2021
Pre-analytical recommendations and reference values for circulating calprotectin are sample type and assay dependent.
Journal: Clinical chemistry and laboratory medicine
Published: September 10, 2021
Titre-specific positive predictive value of antinuclear antibody patterns.
Journal: Annals of the rheumatic diseases
Published: September 02, 2019
Pre-analytical and analytical confounders of serum calprotectin as a biomarker in rheumatoid arthritis.
Journal: Clinical chemistry and laboratory medicine
Published: May 20, 2019
Added Value of Fecal Calprotectin to Support the Diagnosis of Spondyloarthropathies.
Journal: The Journal of rheumatology
Published: February 03, 2019
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.
Journal: Acta gastro-enterologica Belgica
Published: March 22, 2018
Last Updated: 09/26/2026